Search

everythinglearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

S100A4 and NMIIA promote tumor growth in glioblastoma by enhancing blood vessel functions.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

PRP derivatives are likely safe for therapeutic use without harmful effects.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

PRDX5 enzyme may contribute to alopecia areata by affecting oxidative stress and autoimmunity.

MsPG3 protein gathers at root hair tips, aiding growth.

Hair plucking quickly increases antizyme, reducing a specific enzyme activity in rats.

Generative AI tools like GPT-4o can effectively automate SALT scoring for alopecia areata, matching clinician accuracy.

Type IV collagen chains vary in different parts of human skin, with specific patterns linked to melanocytes.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

Qu-shi-yu-fa Decoction may help treat hair loss by promoting hair growth and strengthening hair follicles.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Cyclic nucleotide-gated channels are crucial for proper root hair growth and calcium balance in plants.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

A woman developed rare, unexplained curly hair on her scalp and eyelashes.

A compromised gut may trigger the autoimmune hair loss condition Alopecia Areata.

The genetic variation in the KAP13-3 gene may affect cashmere fiber traits in Liaoning goats.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

High S100A4 levels worsen glioblastoma by promoting blood vessel growth.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Impaired LEF1 activation speeds up skin cell development in Hutchinson-Gilford Progeria Syndrome.

The document describes a rare case of IFAP syndrome, a genetic condition with symptoms of hair loss, light sensitivity, and scaly skin.

Shh and Dhh affect skin development and can cause tumors, while Ihh does not.

MPZL3 is crucial for seborrheic dermatitis development.

A specific gene mutation causes a severe skin disorder in a family.

Glycine is a key transmitter in rat spinal cord synapses, often alongside GABA.

A(1-7) treatment reduces symptoms of lupus in mice.

A patient developed a blister at the injection site after hepatitis C treatment.